Investigation for chronic Idiopathic Urticaria
Not Applicable
- Conditions
- urticaria.Idiopathic urticaria
- Registration Number
- IRCT2013030912758N1
- Lead Sponsor
- Iraqi Board for Medical specializations
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
All patients with chronic idiopathic urticaria who have active urticaria at time of presentation and the current attack started at least six week before the test.
Exclusion criteria: children younger than 15 years of age and pregnant women were excluded from the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wheal and flare. Timepoint: 30 minutes after intradermal injection of 0.05 ml of the patient’s serum into patient’s forearm. Method of measurement: wheal and flare at the tested site of a diameter (measured by taking the mean of the largest two diameters) at least 1.5 millimeters more than the wheal and flare induced at the control site.
- Secondary Outcome Measures
Name Time Method Wheal and flare. Timepoint: 45 minutes after intradermal injection of the patient’s serum into patient’s forearm. Method of measurement: wheal and flare at the tested site of a diameter (measured by taking the mean of the largest two diameters) at least 1.5 millimeters more than the wheal and flare induced at the control site.